Publication & Citation Trends
Publications
0 total
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. OA
Cited by 208
Semantic Scholar
Quality assurance review center: Role in multi-institutional breast cancer trials.
Cited by 1
Semantic Scholar
ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer.
Cited by 21
Semantic Scholar
A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer.
Cited by 10
Semantic Scholar
The academic oncology hospitalist--a model for improved teaching and patient care
Cited by 1
Semantic Scholar
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer OA
Cited by 766
Semantic Scholar
CirculatingTumor Cells versus ImagingPredicting Overall Survival in Metastatic Breast Cancer
Cited by 1
Semantic Scholar
Circulating tumor cells versus imaging : Predicting overall survival in metastatic breast cancer. Commentary
Cited by 6
Semantic Scholar
Research Topics
Cardiac, Anesthesia and Surgical Outcomes
(7)
Hip and Femur Fractures
(5)
Hemodynamic Monitoring and Therapy
(5)
Cancer Cells and Metastasis
(4)
HER2/EGFR in Cancer Research
(4)
Affiliations
Cleveland Clinic
Sunnybrook Health Science Centre
Royal Marsden NHS Foundation Trust
The University of Texas MD Anderson Cancer Center
University of Arizona